STACY RIEDT: Open Payments
NPI 1982926317 · MONTPELIER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 22 payments from 10 companies in 2025. Trend: 2023 $793 · 2024 $466 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $174 |
| Lilly USA, LLC | 2 | $44 |
| PFIZER INC. | 2 | $34 |
| Tris Pharma Inc | 2 | $30 |
| Novo Nordisk Inc | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Abbott Laboratories | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: FARXIGA, AIRSUPRA, BREZTRI, MOUNJARO, Dyanavel XR, Wegovy, The Cologuard Plus Collection Kit, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
